CD37 and acute myeloid leukemia: The HH1 anti-CD37 antibody-based CAR (CD37CAR), previously tested in B-NHL,32 was tested against AML and shown to be of comparable efficiency to the CD33CAR, with the advantage of being less toxic against healthy cells.